1995
DOI: 10.1002/eji.1830250823
|View full text |Cite
|
Sign up to set email alerts
|

Antigen receptor‐initiated growth inhibition is blocked in CD45‐loss variants of a mature B lymphoma, with limited effects on apoptosis

Abstract: Role of CD45 in B cell antigen receptor (BcR)-mediated signaling events in mature B cells was examined using BAL-17 and its CD45-negative clones. In the CD45-negative clones, BcR stimulation induced tyrosine phosphorylation almost identical to the parental cells, with a few exceptions of reduced phosphorylation, especially of a protein of about 60 kDa. BcR-induced calcium responses were reduced in the CD45-negative clones, but the kinetics were similar to the parent. BcR stimulation led to growth inhibition in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

1997
1997
2005
2005

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 22 publications
(27 citation statements)
references
References 38 publications
1
26
0
Order By: Relevance
“…30,31 We further showed that, in WEHI-231 cells, CD45 constitutively inhibits Lyn by dephosphorylating both the COOH-terminal and autophosphorylation sites, but that BCR ligation induces phosphorylation of the 2 sites. 27, 28 We therefore suggested that the inhibitory activity of CD45 was somehow diminished upon BCR ligation.…”
Section: Introductionmentioning
confidence: 83%
See 1 more Smart Citation
“…30,31 We further showed that, in WEHI-231 cells, CD45 constitutively inhibits Lyn by dephosphorylating both the COOH-terminal and autophosphorylation sites, but that BCR ligation induces phosphorylation of the 2 sites. 27, 28 We therefore suggested that the inhibitory activity of CD45 was somehow diminished upon BCR ligation.…”
Section: Introductionmentioning
confidence: 83%
“…27,29,31 These cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 50 M 2-mercaptoethanol (2-ME), 100 g/mL streptomycin, and 100 U/mL penicillin. CD45 exon 9 knock-out (KO) 38 and C57BL/6 (B6) mice were obtained from Jackson Laboratory (Bar Harbor, ME) and Japan SLC (Hamamatsu, Japan), respectively, and used at 6 to 12 weeks of age.…”
Section: Cell Culturementioning
confidence: 99%
“…The tyrosine phosphatase CD45 is required for efficient BCR signal transduction (23,24,(34)(35)(36)(37)(38). As a consequence, CD45 deficiency promotes survival and accumulation of self-reactive B cells in vivo (38).…”
Section: Receptor Editing In B Cells From Hemizygous 3-83igi;h-2 D Mimentioning
confidence: 99%
“…Cells-The WEHI-231 and BAL-17 murine B cell lines and the BAL-17-derived, CD45-deficient clone 44 were all described previously (35,36). All cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum, 50 M 2-mercaptoethanol, 100 g/ml streptomycin, and 100 units/ml penicillin (complete medium).…”
Section: Methodsmentioning
confidence: 99%
“…Proliferation Assay-Proliferation assay was performed as previously described (35,36 Electroporation-To introduce DNA into cells, 2 ϫ 10 7 cells were washed twice with phosphate-buffered saline and suspended with 0.4 ml of cytomix buffer (120 mM KCl, 0.15 mM CaCl 2 , 10 mM K 2 HPO 4 / KH 2 PO 4 , pH 7.6, 25 mM HEPES, pH 7.6, 2 mM EGTA, pH 7.6, 5 mM MgCl 2 , 2 mM ATP, and 5 mM glutathione) containing 40 g of DNA, and electroporated at 264 V, 950 microfarads. DNAs introduced were: the pcDLSR␣ expression vector containing Src-CD45 (a chimeric cDNA encoding the intracellular murine CD45 preceded by a short aminoterminal sequence from p60 c-src ) (38) or the pcDLSR␣ empty vector (a gift from Dr. Y. Minami, Kobe University, Kobe, Japan), and pEFII expression vector containing a gene encoding a hemagglutinin-tagged dominant-negative SEK1 mutant (SEK-AL) (39) (a gift of Dr. Jim Woodgett, Ontario Cancer Institute, Toronto, Canada), which had been excised from pcDNA3 Zeo, or the empty vector (a gift from Dr. G. Koretzky, University of Pennsylvania, Philadelphia, PA).…”
Section: Methodsmentioning
confidence: 99%